您的位置:首页 > 产品中心 > 186185-03-5, BMS-193885
BMS-193885
产品别名
186185-03-5
BMS-193885
1,4-dihydro-4-[3-[[[[3-[4-(3-methoxyphenyl)-1-piperidinyl]propyl]amino]carbonyl]amino]phenyl]-2,6-dimethyl-3,5-dimethyl ester-3,5-pyridinedicarboxylic acid
结构式
基本信息
Empirical Formula【经验(实验)分子式】 | C33H42N4O6 |
Molecular weight | 590.71 |
MDL number | MFCD16878998 |
PubChem Substance ID【PubChem化学物质编号】 | 329773248 |
NACRES | NA.77 |
Biochem/physiol Actions【生化/生理作用】 | BMS-193885 is a potent, selective Y1 antagonist that is active in both acute and chronic animal models of food intake. Although it is active in vivo, it is not orally bioavailable due to poor intestinal absorption, so it is not being pursued for pharmaceutical development. BMS-193885 has been used as a pre-clinical proof of concept tool for showing efficacy of Y1 antagonism in treating obesity. |
Features and Benefits【特点和优势】 | This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. This compound is featured on the Neuropeptide Y Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here. |
产品性质
Quality Level【质量水平】 | 100 |
Assay【测定】 | ≥98% (HPLC) |
form【形式】 | powder |
color【颜色】 | light yellow to yellow |
solubility【溶解性】 | DMSO: >10 mg/mL |
originator【创始人】 | Bristol-Myers Squibb |
storage temp.【储存温度】 | −20℃ |
SMILES string | COC(=O)C1=C(C)NC(C)=C(C1c2cccc(NC(=O)NCCCN3CCC(CC3)c4cccc(OC)c4)c2)C(=O)OC |
InChI | 1S/C33H42N4O6/c1-21-28(31(38)42-4)30(29(22(2)35-21)32(39)43-5)25-10-6-11-26(19-25)36-33(40)34-15-8-16-37-17-13-23(14-18-37)24-9-7-12-27(20-24)41-3/h6-7,9-12,19-20,23,30,35H,8,13-18H2,1-5H3,(H2,34,36,40) |
InChI key | WMYSXJSJXZFODY-UHFFFAOYSA-N |
packaging【包装】 | 5, 25 mg in glass bottle |
安全信息
Pictograms【象形图】 | GHS07 |
Signal word【警示用语:】 | Warning |
Hazard Statements | H302 |
Hazard Classifications【危险分类】 | Acute Tox. 4 Oral |
Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
WGK | WGK 3 |